Drug intelligence / Profile preview

cornus officinalis total terpenes

Development stage
Unknown
Lead developer
Cinkate
Modality
Small Molecules
Administration
Oral
01

Overview

Cornus officinalis total terpenes is a botanical drug candidate derived from the fruit of *Cornus officinalis* (Japanese cornel dogwood), a plant widely used in Traditional Chinese Medicine. Developed by Suzhou Changzheng-Xinkai Pharmaceutical, this extract is a purified fraction primarily composed of iridoid glycosides, including loganin and morroniside. It is being investigated for the treatment of type 2 diabetes mellitus. The drug is thought to exert its therapeutic effects by improving insulin sensitivity, enhancing glucose uptake, and protecting pancreatic beta cells from oxidative stress and apoptosis. Preclinical studies suggest that these effects are mediated through the activation of the AMPK signaling pathway and the modulation of glucose transporters.

Other names
total terpenes of Cornus officinalisShan Zhu Yu total terpenesiridoid glycosides of Cornus officinalisCornus officinalis total iridoid glycosides
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on cornus officinalis total terpenes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cornus officinalis total terpenes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call